HANA HASSANIN

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£2,530,057

Feb 18 - Sep 21

A phase 1 trial of a retinoic acid receptor beta agonist for the treatment of spinal cord injury

MRC award to King's College London and Jonathan Corcoran

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}